Inactive Instrument

PDL BioPharma, Inc. Stock price

Equities

PDLI

US69329Y1047

Biotechnology & Medical Research

Dynamic Chart
Managers TitleAgeSince
Chief Executive Officer 59 09-02-01
Director of Finance/CFO - 16-12-31
Director/Board Member 72 08-09-30
Members of the board TitleAgeSince
Director/Board Member 65 17-09-10
Director/Board Member 72 08-09-30
Chief Executive Officer 59 09-02-01
More insiders
PDL BioPharma, Inc. has a portfolio of income generating assets based on alternative financings. These alternative financings fall into one of three categories: royalty monetization, debt structures and hybrids of the two. The Company's investments are typically in assets with strong intellectual property protection and are commercial stage or soon-to-be approved. The counterparties in these transactions can be biotechs, pharmas, medtech companies, universities and inventors.
More about the company
  1. Stock
  2. Equities
  3. Stock PDL BioPharma, Inc. - Nasdaq